zidovudine has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Benfield, T; Kjaer, A; Kofoed, K; Kristoffersen, US; Kronborg, G; Lebech, AM | 1 |
3 other study(ies) available for zidovudine and mocetinostat
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy.
Topics: Adult; Aged; Anti-Retroviral Agents; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Intercellular Adhesion Molecule-1; Longitudinal Studies; Male; Matrix Metalloproteinase 9; Middle Aged; Peroxidase; Risk Factors; Vascular Cell Adhesion Molecule-1; Viral Load; Zidovudine | 2009 |